Bayer Cropscience Ltd stock (INE462A01022): stable trading as investors look at valuation metrics after recent earnings

Bayer Cropscience Ltd shares in India are trading steadily after the latest quarterly results and amid ongoing scrutiny of earnings quality and valuation multiples in the domestic agrochemicals sector.

Bayer Cropscience Ltd shares in India continue to trade in a relatively steady range after the latest quarterly numbers, as investors reassess the company’s earnings profile and valuation against the broader agrochemicals segment on the local market.

On the BSE in India, Bayer Cropscience Ltd (ticker: 506285) most recently changed hands around the mid-5,000 rupees level per share, with Business Standard data showing a close of ?5,350.70 on 09/19/2025, up 2.87% from the previous close of ?5,201.55 according to Business Standard as of 09/19/2025.

For international investors, the stock is also tracked on Indian exchanges under the symbol BAYERCROP on the NSE, with the same ISIN INE462A01022 and a sector classification in agrochemicals and crop-protection inputs as reported by Moneycontrol as of 12/2025.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Bayer Crop
• Sector/industry: Pesticides and agrochemicals
• Headquarters/country: Thane, India
• Core markets: India and selected export markets for crop protection products and seeds
• Key revenue drivers: Crop protection formulations, seeds and traits, and related agricultural solutions sold to farmers and distributors in India
• Home exchange/listing venue: BSE (506285), NSE (BAYERCROP)
• Trading currency: INR

Bayer Cropscience Ltd: core business model

Bayer Cropscience Ltd focuses on supplying Indian agriculture with crop-protection chemicals, seeds and allied solutions, with revenue largely driven by seasonal demand patterns, product mix between herbicides, insecticides and fungicides, and pricing power across key domestic regions.

Valuation metrics and multiples for Bayer Cropscience Ltd

On valuation, local market data providers place Bayer Cropscience Ltd within the Indian pesticides and agrochemicals universe, where peers typically trade at mid- to high-teens forward earnings multiples, while some premium names command P/E ratios above 20 times on the back of stronger growth expectations, according to sector snapshots on Moneycontrol as of 12/2025.

A more detailed breakdown from independent research on Bayer Cropscience Ltd’s Q4 FY26 performance highlights that the company has managed to support margins even as top-line expansion remains relatively modest, which feeds directly into how investors debate the appropriate earnings multiple for the stock, as discussed in analysis by MarketsMojo as of Q4 FY26.

Conclusion

Bayer Cropscience Ltd shares on the Indian market are currently trading in a stable corridor, with investors weighing recent quarterly results against the broader demand backdrop for crop-protection inputs.

Valuation metrics remain a central focus as the company’s ability to defend margins while pursuing sustainable revenue growth continues to shape how the stock is positioned within the domestic pesticides and agrochemicals universe.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.